Effect of a Six-week Integrated Attention Training Program on the Cognitive Functions of Older Adults With Co-occurring Anxiety Symptoms and Subjective Cognitive Complaints
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this single-blind randomized control trial is to compare a 6-week Integrated Attention Training Program (IATP) and health education in older people with co-occurrence of anxiety symptoms and subjective cognitive decline (SCC). The study aims to answer if a 6-week Integrated Attention Training Program (IATP) will improve cognitive, anxiety, and level of pro-inflammatory biomarkers in this high-risk group. Older adults with co-occurring anxiety and SCC will be recruited to participate in a 6-week single-blind randomized controlled trial. IATP group (Intervention group) will undergo attention and functional training. Control group will receive health education. Investigators will compare the IATP with health education to see if cognitive function, anxiety symptoms, and level of pro-inflammatory biomarkers in comparison to health education will improved after intervention and over 24 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Jul 2023
Typical duration for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 29, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMarch 4, 2026
October 1, 2024
2 years
August 29, 2023
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Attention - Digit Span Forward Task
Participants are asked to repeat a series of digits immediately after presentation, in ascending order starting from 3 and up to 8 digits. Analysis of scoring is based on the span length achieved.
6 weeks after baseline and 6 months after baseline
Attention - Chinese Trail Making Test - Part A (CTMT-A)
The participant will need to connect between Arabic and Chinese numbers in sequential order. The completion time (in second) and the numbers of errors made during the test are recorded
6 weeks after baseline and 6 months after baseline
Executive function - Category Verbal Fluency Test (CVFT)
It is test of semantic fluency and executive function. Participants were asked to generate as many exemplars as possible for each of the three semantic categories, namely animals, fruits, and vegetables, in 60 seconds. Their responses were recorded in serial order. Analysis of scoring is based on the total number of words that the participant is able to produce across all three categories.
6 weeks after baseline and 6 months after baseline
Executive function - Digit Span Backwards Task
Participants will be asked to repeat a series of digits immediately after presentation, in reverse order starting from 2 and up to 8 digits. Analysis of scoring is based on the span length achieved.
6 weeks after baseline and 6 months after baseline
Executive function - Chinese Trail Making Test - Part B (CTMT-B)
The participant will need to connect and alternate between Arabic and Chinese numbers. The completion time (in second) and the numbers of errors made during the test are recorded.
6 weeks after baseline and 6 months after baseline
Anxiety symptoms
Hamilton Anxiety Scale (HAM-A) - each item will be scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where 17 or less indicates a mild severity, 18-24 indicates a mild to moderate severity and 25-30 a moderate to severe severity.
6 weeks after baseline and 6 months after baseline
Level of inflammation
Levels of IL-1β
6 weeks after baseline and 6 months after baseline
Level of inflammation
Levels of IL-6
6 weeks after baseline and 6 months after baseline
Level of inflammation
Levels of TNF-α
6 weeks after baseline and 6 months after baseline
Level of inflammation
Levels of CRP
6 weeks after baseline and 6 months after baseline
Secondary Outcomes (1)
Functional performance - Chinese version of Disability of Assessment in dementia (CDAD)
6 weeks after baseline and 6 months after baseline
Study Arms (2)
IATP
EXPERIMENTALControl
NO INTERVENTIONInterventions
Integrated Attention Training Program (IATP) specifically aims at training attentional control, which involves the coordination of complex behaviours, such as planning, reasoning, selection and information inhibition.
Eligibility Criteria
You may qualify if:
- Older adults aged 60 to 90 years;
- No Major Neurocognitive Disorders
- Presence of anxiety symptoms
- Presence of Subjective Cognitive Complaints
You may not qualify if:
- Clinical dementia
- History of major depression
- Presence of major neurological deficit
- Presence of severe visual impairment; or
- Currently on any psychotropic or other medications known to affect cognition; or
- Participation in other cognitive trainings or interventions 6 months prior to this study or during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ada WT FUNG
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ada WT FUNG, PhD
Hong Kong Baptist University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2023
First Posted
October 2, 2023
Study Start
July 1, 2023
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
March 4, 2026
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
Dissimination through conference presentation and publications